Search research articles
Contact Us
Filters
Showing results (201-210 of 538) with videos related to
Page
of 54
Sort By:
Journal of Neuro-Oncology
|
November 9, 2017
Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors
Derek R Johnson, Christopher H Hunt, Mark A Nathan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Jianqiao Tian, Wen Zhang, Sheelakumari Raghavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 24, 2023
Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease
Irene Sintini, Jonathan Graff-Radford, Christopher G Schwarz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2021
Comparison of <sup>11</sup>C-Pittsburgh Compound B and <sup>18</sup>F-Flutemetamol White Matter Binding in PET
Burcu Zeydan, Christopher G Schwarz, Scott A Przybelski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Ariane Bollack, Beatrice Orso, Mahnaz Shekari, et al.
Neurology
|
April 22, 2024
Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Maria Vassilaki, Rioghna R Pittock, Jeremiah A Aakre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 12, 2025
Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET
Elijah Mak, Scott A Przybelski, Heather J Wiste, et al.
Nuclear Medicine Communications
|
September 13, 2024
Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum
Burcu Zeydan, Derek R Johnson, Christopher G Schwarz, et al.
Neurology
|
August 16, 2023
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Rioghna R Pittock, Jeremiah A Aakre, Anna M Castillo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2018
MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy
Jennifer L Whitwell, Nirubol Tosakulwong, Christopher G Schwarz, et al.
Page
of 54
Search research articles
Search
Showing results (201-210 of 538) with videos related to
Sort By:
Page
of 54
Journal of Neuro-Oncology
|
November 9, 2017
Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors
Derek R Johnson, Christopher H Hunt, Mark A Nathan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Jianqiao Tian, Wen Zhang, Sheelakumari Raghavan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 24, 2023
Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease
Irene Sintini, Jonathan Graff-Radford, Christopher G Schwarz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2021
Comparison of <sup>11</sup>C-Pittsburgh Compound B and <sup>18</sup>F-Flutemetamol White Matter Binding in PET
Burcu Zeydan, Christopher G Schwarz, Scott A Przybelski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Ariane Bollack, Beatrice Orso, Mahnaz Shekari, et al.
Neurology
|
April 22, 2024
Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Maria Vassilaki, Rioghna R Pittock, Jeremiah A Aakre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 12, 2025
Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET
Elijah Mak, Scott A Przybelski, Heather J Wiste, et al.
Nuclear Medicine Communications
|
September 13, 2024
Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum
Burcu Zeydan, Derek R Johnson, Christopher G Schwarz, et al.
Neurology
|
August 16, 2023
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Rioghna R Pittock, Jeremiah A Aakre, Anna M Castillo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2018
MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy
Jennifer L Whitwell, Nirubol Tosakulwong, Christopher G Schwarz, et al.
Page
of 54